SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) September 7, 2000
BICO, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (CommissionFile Number) (IRS Employer
of incorporation) identification No.)
2275 Swallow Hill Road, Bldg. 2500, Pittsburgh, Pennsylvania 15220
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 429-0673
_________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
BICO, Incorporated , announced today that Dr.
Leopold W. Miksche, the former Corporate Medical
Director of Bayer AG and Head of the Department
for Occupational Health for the BAYER Group, has
joined BICO as its Chief Medical Advisor,
effective September 1, 2000.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information and Exhibits.
(a) Financial Statements and Businesses Acquired - Not Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities ExchangeAct of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
BICO, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: September 7, 2000
DR. LEOPOLD W. MIKSCHE, FORMER CORPORATE MEDICAL DIRECTOR OF
BAYER AG, JOINS BICO
Pittsburgh, PA - September 7, 2000 - BICO, Incorporated
(OTCBB:BICO) announced today that Dr. Leopold W. Miksche,
the former Corporate Medical Director of BAYER AG and Head
of the Department for Occupational Health for the BAYER
Group, has joined BICO as its Chief Medical Advisor,
effective September 1, 2000.
In this position, Dr. Miksche, who received his medical
degree from the University of Heidelberg in Germany and
worked for BAYER AG (the parent of BAYER Corporation U.S.)
from 1978 to 1998, will initially focus on the ThermoChem-
HTT System and assist with the Diasensorr2000 noninvasive
glucose monitor in the European medical community.
The ThermoChem-HT System and disposables, which are
products of BICO subsidiary ViaCirQ, Inc., received FDA
marketing clearance in December 1999 for use in
intraperitoneal hyperthermia procedures to treat cancer.
In May 2000, Biocontrol Technology, a division of BICO,
was given clearance to CE Mark the Diasensor 2000, allowing
marketing in the European Community. The Diasensor 2000 is
currently in the FDA approval process in the U.S.
Of the new Chief Medical Advisor, BICO Chief Executive
Officer Fred E. Cooper said, "With his vast corporate
medical experience and knowledge, Dr. Miksche is a very
valuable addition to our efforts to provide product
information and gain acceptance in the medical community.
We are very excited with Dr. Miksche's confidence in our
products and his decision to join BICO."
BICO, Inc. has its corporate offices in Pittsburgh, PA
and is involved in the development and manufacture of
biomedical devices and environmental products. Subsidiary
ViaCirQ, Inc., also located in Pittsburgh, develops and
markets extracorporeal hyperthermia medical devices.
Biocontrol Technology, Inc., a division of BICO, is located
in Indiana, PA, manufactures the ThermoChem-HT System, and
concentrates on the Diasensor 2000 noninvasive glucose
monitor development and manufacturing.
FOR FURTHER INFORMATION, CONTACT:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204 WEBSITE: www.bico.com
